Flaxeladol, the less opioidergic enantiomer, was patented as fast-acting antidepressant and anxiolytic, superior to venlafaxine and diazepam, respectively. These effects were naloxone-reversible, i.e. caused by µ-opioid stimulation. They didn't do much research with the opposite enantiomer, which is 5 times more potent as opioid. They've probably foreseen trouble with such a potent opioid and the marketing of it. The racemate, which is obtained when plain tramadol is converted to flaxeladol, should have just the right pharmacology: as µ-opioid similar or slightly less potent than morphine, with some added rather weak monoamine reuptake effects, which become effective in the case of abuse of high doses. Estimated dose range: 20 - 200mg, similar to other black market opioids (morphine, heroin, oxycodone), so not too prone for ODs like the ultra-potent opioids some were dreaming of bringing to the market. Raceflaxeladol (suggestions for a better name?), a fast acting antidepressant anxiolytic opioid that's legal and not even an analog should be able to help many people with drug (opioid) problems. Next project: a similar improved, harm reduced replacement for cocaine.